1 min to read News Posted on February 9, 2023 Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC … – MedCity News Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC … MedCity News Source: Weight Loss in a Pill Device Firm Allurion Heads to NYSE via SPAC … – MedCity News share tweet share By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawWhat Will Crypto SPACs Look Like in 2023?SPACs: Are You Really Ready To Commit?Report: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPAC Tags: SPACs